Circulating oxidized LDL levels, current smoking and obesity in postmenopausal women

Atherosclerosis

Volumn 205, Issue 1, 2009, Pages 279-283

  Kassi, E ^a   Dalamaga, M ^a   Faviou, E ^a   Hroussalas, G ^a   Kazanis, K ^a   Nounopoulos, Ch ^a   Dionyssiou Asteriou, A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Menopause; Obesity; Oxidized LDL levels; Smoking

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; OXIDATIVE STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BODY MASS INDEX; FEMALE; HUMANS; LIPOPROTEINS, LDL; MIDDLE AGED; OBESITY; POSTMENOPAUSE; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; TOBACCO USE DISORDER;

EID: 67349088765     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.11.006     Document Type: Article

References (40)

1. Holvoet P., Harris T.B., Tracy R.P., et al. Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging, And Body Composition Study. Arterioscler Thromb Vasc Biol 23 (2003) 1444-1448
2. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340 (1999) 115-126
3. Holvoet P., and Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J 8 (1994) 1279-1284
4. Toshima S., Hasegawa A., Kurabayashi M., et al. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 20 (2000) 2243-2247
5. Ehara S., Ueda M., Naruko T., et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103 (2001) 1955-1960
6. Faviou E., Vourli G., Nounopoulos C., Zachari A., and Dionyssiou-Asteriou A. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease. Free Radic Res 39 (2005) 419-429
7. Faviou E., Vourli G., Zachari A., Nounopoulos C., and Dionyssiou-Asteriou A. Correlation of lipid peroxidation with age, gender and life habits in a healthy Greek population. Free Radic Res 39 Suppl. (2005) S57
8. Holvoet P., Jenny N.S., Schreiner P.J., Tracy R.P., and Jacobs D.R. The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 194 (2007) 245-252
9. Itabe H., Yamamoto H., Imanaka T., et al. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J Lipid Res 37 (1996) 45-53
10. Ambrose J.A., and Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43 (2004) 1731-1737
11. van Baal W.M., Kooistra T., and Stehouwer C.D. Cardiovascular disease risk and hormone replacement therapy (HRT): a review based on randomised, controlled studies in postmenopausal women. Curr Med Chem 7 (2000) 499-517
12. Signorelli S.S., Neri S., Sciacchitano S., et al. Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 53 (2006) 77-82
13. Walsh B.W., Schiff I., Rosner B., et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325 (1991) 1196-1204
14. Deibert P., Koning D., Vitolins M.Z., et al. Effect of a weight loss intervention on anthropometric measures and metabolic risk factors in pre- versus postmenopausal women. Nutr J 6 (2007) 31
15. Sowers J.R. Obesity as a cardiovascular risk factor. Am J Med 115 Suppl. (2003) 37S-41S
16. Keaney Jr. J.F., Larson M.G., Vasan R.S., et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study. Arterioscler Thromb Vasc Biol 23 (2003) 434-439
17. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., and Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282 (1999) 2131-2135
18. You T., Ryan A.S., and Nicklas B.J. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. J Clin Endocrinol Metab 89 (2004) 5517-5522
19. Holvoet P., Mertens A., Verhamme P., et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21 (2001) 844-848
20. Bouloumie A., Marumo T., Lafontan M., and Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 13 (1999) 1231-1238
21. Rosenson R.S. Statins in atherosclerosis: lipid-lowering agents with antioxidants capabilities. Atherosclerosis 173 (2004) 1-12
22. Porreca E., Di Febbo C., Moretta V., et al. Circulating leptin is associated with oxidized LDL in postmenopausal women. Atherosclerosis 175 (2004) 139-143
23. Yamagishi S.I., Edelstein D., Du X.L., et al. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 276 (2001) 25096-25100
24. Rashid S., and Genest J. Effect of obesity on high-density lipoprotein metabolism. Obesity 15 (2007) 2875-2888
25. Sigurdardottir V., Fagerberg B., and Hulthe J. Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). J Intern Med 252 (2002) 440-447
26. Watson A.D., Berliner J.A., Hama S.Y., et al. Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 96 (1995) 2882-2891
27. Navab M., Berliner J.A., Subbanagounder G., et al. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol 21 (2001) 481-488
28. Persegol L., Verges B., Gambert P., and Duvillard L. Inability of HDL from abdominally obese subjects to counteract the inhibitory effect of oxidized LDL on vasorelaxation. J Lipid Res 48 (2007) 1396-1401
29. Myara I., Alamowitch C., Michel O., et al. Lipoprotein oxidation and plasma vitamin E in nondiabetic normotensive obese patients. Obes Res 11 (2003) 112-120
30. Monaco C., Crea F., Niccoli G., et al. Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease. Eur Heart J 22 (2001) 1572-1577
31. Yla-Herttuala S., Palinski W., Butler S.W., et al. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb 14 (1994) 32-40
32. Suzuki K., Ito Y., Ochiai J., et al. The relationship between smoking habits and serum levels of 8-OHdG, oxidized LDL antibodies, Mn-SOD and carotenoids in rural Japanese residents. J Epidemiol 13 (2003) 29-37
33. Wu R., de Faire U., Lemne C., Witztum J.L., and Frostegard J. Autoantibodies to oxLDL are decreased in individuals with borderline hypertension. Hypertension 33 (1999) 53-59
34. Scott B., Liblau R., Degermann S., et al. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1 (1994) 73-83
35. Virella G., Koskinen S., Krings G., et al. Immunochemical characterization of purified human oxidized low density lipoprotein antibodies. Clin Immunol 95 (2000) 135-144
36. Delimaris I., Faviou E., Antonakos G., et al. Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. Clin Biochem 40 (2007) 1129-1134
37. Grundy S.M., Pasternak R., Greenland P., Smith S., and Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equation: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 100 (1999) 1481-1492
38. Bernhard D., and Wang X.L. Smoking, oxidative stress and cardiovascular diseases do anti-oxidative therapies fail?. Curr Med Chem 14 (2007) 1703-1712
39. Bernhard D., Csordas A., Henderson B., et al. Cigarette smoke metal-catalyzed protein oxidation leads to vascular endothelial cell contraction by depolymerization of microtubules. FASEB J 19 (2005) 1096-1107
40. Yong E.L., Li J., and Liu M.H. Single gene contributions: genetic variants of peroxisome proliferators-activated receptor (isoforms alpha, beta/delta and gamma) and mechanisms of dyslipidemias. Curr Opin Lipidol 19 (2008) 106-108